Skip to main content
. 2018 Sep 6;9:1960. doi: 10.3389/fimmu.2018.01960

Table 4.

Fatty acid composition (% of TFA) and content in liver neutral lipids of zebrafish fed with a diet supplemented (w/w) with different levels (7.5 and 15%) of the microalga Lobosphaera incisa WT and mutant P127.

Fatty acid Before challenge After challenge
WT 7.5 % WT 15 % MUT 7.5% MUT 15% Control WT 7.5 % WT 15 % MUT 7.5% MUT 15% Control
14:0 1.8 ± 0.3 1.9 ± 0.2 1.8 ± 0.1 1.8 ± 0.1 1.8 ± 0.2 2.1 ± 0.1 1.2 ± 0.8 1.4 ± 0.9 2.3 ± 1.1 1.8 ± 0.4
16:0 22 ± 1.3 21.4 ± 0.2 20.7 ± 0.5 20.4 ± 0.8 22.6 ± 1.0 30.2 ± 1.8 24.9 ± 3.1 23.8 ± 0.1 21.2 ± 3.8 24.4 ± 2.6
16:1n-5 0.8 ± 0.1 0.7 ± 0.1 0.9 ± 0.3 0.7 ± 0.1 0.8 ± 0.2 0.3 ± 0.5 0.4 ± 0.4 0.5 ± 0.4 0.6 ± 1.6 1.3 ± 2.1
16:1n-7 3.6 ± 0.4 3.6 ± 0.5 3.2 ± 0.2 3.2 ± 0.2 3.9 ± 0.2 2.9 ± 2.5 2.6 ± 1.9 2.2 ± 1.4 3.7 ± 0.4 2.9 ± 2.7
16:2 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.2 0.3 ± 0.1 0.3 ± 0.2 0.4 ± 0 0.4 ± 0.4 0.4 ± 0.2 0.5 ± 0 0.3 ± 0.3
16:2 0.5 ± 0.2 0.5 ± 0.2 0.8 ± 0.1 0.5 ± 0.4 0.5 ± 0.1 2.5 ± 2.6 0.5 ± 0.2 2.7 ± 4.1 0.6 ± 0.7 1.7 ± 1.1
16:3 0.7 ± 0.3 0.7 ± 0.1 0.6 ± 0.1 0.5 ± 0 0.6 ± 0.1 0.6 ± 0.3 0.8 ± 0.6 0.6 ± 0.4 0.6 ± 0.3 1.0 ± 0.7
18:0 4.3 ± 0.4 4.2 ± 0.1 4.8 ± 0.8 4.5 ± 0.4 4.4 ± 0.2 9.1 ± 1.4 8.7 ± 1.8 13.0 ± 11.1 4.1 ± 7.1 10.6 ± 7.2
18:1n-9 27.2 ± 1 27.4 ± 1.5 29.1 ± 2.8 30.5 ± 0.6 30.1 ± 1.0 25 ± 4.0 26.4 ± 1 18.4 ± 9.4 29 ± 6.0 24.9 ± 9.1
18:1n-7 3.0 ± 0.2 3.0 ± 0.1 2.8 ± 0.2 2.7 ± 0.2 2.9 ± 0.3 2.9 ± 0.1 2.7 ± 1.1 2.6 ± 1.3 3.4 ± 0.1 2.5 ± 1.0
18:2n-6 15.5 ± 0.6 15 ± 0.9 15.1 ± 1.9 15 ± 1.3 13.8 ± 1.1 8.9 ± 0.1 10.8 ± 4.1 8.1 ± 5.4 14.5 ± 1.7 11.2 ± 2
18:3n-6 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.1 0.4 ± 0.0 0.3 ± 0.0 0.1 ± 0.1 0.6 ± 0.6 0.1 ± 0.1 0.4 ± 0.2 0.2 ± 0.1
18:3n-3 2.1 ± 0.3 2.0 ± 0.2 2.0 ± 0.2 2.0 ± 0.5 2.0 ± 0.6 0.7 ± 0.1 1.2 ± 1.0 1.3 ± 1.0 2.4 ± 0.6 1.4 ± 1.6
18:4n-3 0.8 ± 0.1 0.8 ± 0.1 0.9 ± 0 0.8 ± 0.2 0.7 ± 0.1 0.8 ± 0.0 0.8 ± 0.4 0.7 ± 0.3 0.9 ± 0.3 0.6 ± 0.4
20:0 0.4 ± 0.1 0.4 ± 0.2 1.2 ± 0.6 0.3 ± 0.1 0.3 ± 0.2 0.2 ± 0.1 0.5 ± 0.5 0.1 ± 0.2 0.2 ± 0.3 0.1 ± 0.1
20:1 2.3 ± 0.1 2.3 ± 0.2 2.1 ± 0.2 2.2 ± 0.2 2.4 ± 0.2 1.6 ± 0.1 2.4 ± 2.8 2.0 ± 1.1 2.2 ± 0 2.3 ± 0.4
20:2 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.4 ± 0.1 0.5 ± 0.2 1.4 ± 0.4 0.3 ± 0.3 0.5 ± 0.1 0.4 ± 0.1 0.3 ± 0.2
20:3n-6 (DGLA) 0.5 ± 0.2c 0.5 ± 0.1c 1.4 ± 0.3b 2.8 ± 0.4a 0.5 ± 0.3c 0.5 ± 0.1 0.6 ± 0.3 1.3 ± 1.3 2.6 ± 0.4 1.1 ± 0.7
20:4n-6 (ARA) 2.1 ± 0.4c 3.3 ± 0.2a 0.7 ± 0.5b 0.6 ± 0.2b 0.4 ± 0.2b 1 ± 0.4 2.1 ± 0.8 2.2 ± 2.1 1.8 ± 0.4 1.1 ± 0.8
20:4n-3 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.1 0.2 ± 0.0 0.2 ± 0.2 0.1 ± 0.2 0.4 ± 0.7 0.4 ± 0.3
20:5n-3 (EPA) 2.6 ± 0.3 2.4 ± 0.4 2.5 ± 0.1 2.5 ± 0.3 2.5 ± 0.5 0.7 ± 0.1 2 ± 0.3 1.2 ± 1.2 2.4 ± 0.4 2.1 ± 0.9
22:0 0.3 ± 0.1 0.3 ± 0.1 0.6 ± 0.4 0.2 ± 0 0.3 ± 0.1 0.6 ± 1.0 0.7 ± 1.0 0.1 ± 0.2 0.0 ± 0.0 0.1 ± 0.1
22:4n-6 0.2 ± 0.1 0.2 ± 0 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 1.3 ± 2.2 0.7 ± 0.7 0.6 ± 1.0 0.2 ± 0.7 0.3 ± 0.2
22:5n-6 0.2 ± 0.1 0.2 ± 0.2 0.4 ± 0.1 0.2 ± 0.1 0.2 ± 0.2 0.4 ± 0.4 0.1 ± 0 0.5 ± 0.2 0.3 ± 0.5 0.2 ± 0.2
22:5n-3 0.8 ± 0.1 0.7 ± 0 0.7 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 1.3 ± 1.9 0.5 ± 0.4 0.9 ± 0.7 0.6 ± 1.5 0.8 ± 0.3
22:6n-3 4.2 ± 0.6 4.1 ± 0.1 4.2 ± 0.4 4.0 ± 0.3 4.3 ± 0.6 1.9 ± 0.5 3.7 ± 0.9 2.4 ± 2.1 3.4 ± 0 3.6 ± 1.8
FA content (μg mg−1 DW)*
DGLA 0.3 ± 0.1b 0.4 ± 0.2b 0.9 ± 0.4ab 1.8 ± 1.2a 0.4 ± 0.2b 0.3 ± 0.2b 0.2 ± 0.1b 0.3 ± 0.2b 1.4 ± 1.0a 0.2 ± 0.1b
ARA 1.6 ± 0.3ab 2.6 ± 1.8a 0.5 ± 0.6b 0.4 ± 0.2b 0.3 ± 0.2b 0.5 ± 0.3b 0.9 ± 0.2b 0.7 ± 0.2a 0.9 ± 0.1ab 0.3 ± 0.2b
TFA 77.4 ± 26.7 78.4 ± 52.4 66.4 ± 32.1 67.1 ± 51.7 91.3 ± 68.4 43.8 ± 19.6 43.7 ± 12.2 26.4 ± 22.1 50.2 ± 15.7 28.3 ± 22.5

Data represents fatty acid composition from the neutral lipid fraction before and after S. iniae challenge. Values shown as mean ± SD, n = 20. Different letters a, b and c denote significant (p < 0.05) difference in treatments, as determined by ANOVA.

*

FA content represents μg of the FA per mg of liver dry weight (DW).